About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	The contents of the displayed table are downloaded as a file named "table.csv".
	A text longer than 100 characters is fully displayed or collapsed.

Target Gene/Pathway Pathway / Gene

Search results

No.

KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related

1

Biosynthesis of cofactors 💬

[1] HPD 💬

Nitisinone 💬

[3] 6 , 164, 241 💬

Disease ID	Name
6	Parkinson disease;Disease Parkinson's;
164	Oculocutaneous albinism;
241	Hypertyrosinemia type I;Tyrosinemia type I;Tyrosinemia I;Hereditary tyrosinemia, Type I;Fumarylacetoacetate hydrolase deficiency;FAH deficiency;

2

Metabolic pathways 💬

[1] HPD 💬

Nitisinone 💬

[3] 6 , 164, 241 💬

Disease ID	Name
6	Parkinson disease;Disease Parkinson's;
164	Oculocutaneous albinism;
241	Hypertyrosinemia type I;Tyrosinemia type I;Tyrosinemia I;Hereditary tyrosinemia, Type I;Fumarylacetoacetate hydrolase deficiency;FAH deficiency;

3

Phenylalanine metabolism 💬

[1] HPD 💬

Nitisinone 💬

[3] 6 , 164, 241 💬

Disease ID	Name
6	Parkinson disease;Disease Parkinson's;
164	Oculocutaneous albinism;
241	Hypertyrosinemia type I;Tyrosinemia type I;Tyrosinemia I;Hereditary tyrosinemia, Type I;Fumarylacetoacetate hydrolase deficiency;FAH deficiency;

4

Tyrosine metabolism 💬

[1] HPD 💬

Nitisinone 💬

[3] 6 , 164, 241 💬

Disease ID	Name
6	Parkinson disease;Disease Parkinson's;
164	Oculocutaneous albinism;
241	Hypertyrosinemia type I;Tyrosinemia type I;Tyrosinemia I;Hereditary tyrosinemia, Type I;Fumarylacetoacetate hydrolase deficiency;FAH deficiency;

5

Ubiquinone and other terpenoid-quinone biosynthesis 💬

[1] HPD 💬

Nitisinone 💬

[3] 6 , 164, 241 💬

Disease ID	Name
6	Parkinson disease;Disease Parkinson's;
164	Oculocutaneous albinism;
241	Hypertyrosinemia type I;Tyrosinemia type I;Tyrosinemia I;Hereditary tyrosinemia, Type I;Fumarylacetoacetate hydrolase deficiency;FAH deficiency;